CorFlow Therapeutics

Switzerland
Baar, Zug, Switzerland
+41 41 544 55 55 ★

Company profile

CorFlow Therapeutics company profile

CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complication rates in these patients.

Business identity

Contact email
[email protected]
Phone number
+41 41 544 55 55
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$10K+
Founded
2016-01-01

Headquarters

Headquarters
Baar, Zug, Switzerland
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
5
Total equity funding
$64.4M
Last funding
Series B / $48.5M / 2024-09-10
Last equity funding
Series B / $48.5M
Investors
15
Lead investors
3
Founders
1
Articles
17

Founders and investors

Founders

Jon H. Hoem

Lead investors

415 CapitalBroadview VenturesPanakes Partners

Investors

415 CapitalMérieux Equity PartnersMonte Carlo CapitalPanakes PartnersWellington Partners

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.